Mao et al. systematically evaluates the integration of digital health technologies (DHT) in 262 clinical trials across ten rare diseases. Results reveal that DHTs enable remote monitoring, digital interventions and patient support, enhancing trial inclusivity, authors also propose a “4A” framework for DHT implementation.
- Xiangyun Mao
- Dian Zeng
- Tien Yin Wong